未知机构：图迈订单破200台海外渗透持续提速事件公司发布公告-20260213

Company and Industry Summary Company: 图迈 (TUMAI) Key Points - Global Commercial Orders: As of February 12, 2026, TUMAI has surpassed 200 global commercial orders for its endoscopic surgical robots, with nearly 130 units installed across close to 50 countries and regions [1][1][1] - Regional Distribution: Among the nearly 50 countries and regions covered, 12 have more than 5 orders each. Notable orders include 14 units in India, over 10 in Brazil, and growth in developed markets such as Spain and Australia [1][1][1] - Clinical Application Depth: Among the installed units, several centers have performed over 100 surgeries, indicating a deepening of "usage after installation" across multiple departments including urology, general surgery, thoracic surgery, and gynecology [1][1][1] - Remote Surgery Expansion: TUMAI has conducted nearly 800 remote surgeries across more than 20 countries, maintaining a 100% success rate. The remote system has received approvals in nearly 10 countries, including China, India, and Brazil, covering regions with nearly half of the global population [1][1][1] Installation Rhythm Review - Order and Installation Milestones: - December 31, 2024: Over 60 commercial orders and 30 installations [2] - October 8, 2025: Over 100 commercial orders and 80 installations [2] - December 24, 2025: Over 160 commercial orders and 100 installations [2] - January 21, 2026: Over 180 commercial orders and 120 installations [2] - February 12, 2026: Over 200 commercial orders and 130 installations [2]